AbbVie News - ABBV

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 73.63 0.00 0.00 0.00 73.63 05:06:18
more quote information »

Recent News

Date Time Source Heading
10/11/201908:57DJNForm 8.3 - Allergan Plc
10/10/201912:41DJNReata Pharmaceuticals Shares Up 8% on Re-Acquiring..
10/10/201908:35DJNForm 8.3 - Allergan Plc
10/10/201907:49DJNReata Pharmaceuticals Reacquires Rights to Bardoxolne
10/09/201909:02DJNForm 8.3 - Allergan Plc
10/09/201902:01PRNUSAbbVie Announces New Data from its Dermatology Portfolio and..
10/08/201908:46DJNForm 8.3 - Allergan Plc
10/08/201908:30PRNUSAbbVie to Host Third-Quarter 2019 Earnings Conference Call
10/07/201910:40DJNForm 8.3 -Allergan Plc
10/04/201909:23DJNForm 8.3 - [Allergan plc]
10/03/201909:52DJNForm 8.3 - Allergan Plc
10/02/201909:20DJNForm 8.3 - Allergan Plc
10/01/201917:56EDGARStatement of Changes in Beneficial Ownership (4)
10/01/201917:53EDGARStatement of Changes in Beneficial Ownership (4)
10/01/201917:51EDGARStatement of Changes in Beneficial Ownership (4)
10/01/201917:49EDGARStatement of Changes in Beneficial Ownership (4)
10/01/201910:52DJNForm 8.3 - [Allergan Plc]
9/30/201909:26DJNForm 8.3 - [Allergan Plc]
9/30/201909:23DJNForm 8.3 - [AbbVie Inc.]
9/27/201917:38DJNFTC Requests for More Information From AbbVie-Allergan..
9/27/201916:16PRNUSAllergan and AbbVie Receive Second Request from Federal..
9/27/201916:15PRNUSAbbVie and Allergan Receive Second Request from Federal..
9/27/201909:36DJNForm 8.3 - [Allergan Inc.]
9/26/201920:00PRNUSAbbVie Receives FDA Approval of MAVYRET®..
9/26/201916:51EDGARCertification by the Exchange Approving Securities for..
9/26/201916:41EDGARSecurities Registration (section 12(b)) (8-a12b)
9/26/201916:07EDGARCurrent Report Filing (8-k)
9/26/201912:19DJNAbbVie Shares Rise After Upgrade From Citigroup
9/26/201910:34DJNForm 8.3 - Allergan Plc
9/25/201910:53DJNForm 8.3 - Allergan Plc
9/25/201909:00PRNCAVENCLEXTA®, a treatment for chronic lymphocytic leukemia..
9/24/201910:50DJNForm 8.3 - Allergan Plc
9/24/201908:45NNWGene Therapies with Potential to Conquer Tough-to-Tackle..
9/23/201916:25EDGARCurrent Report Filing (8-k)
9/23/201910:44DJNForm 8.3 - Allergan Plc
9/23/201903:01PRNUSAbbVie to Present New and Updated Data From 22 Abstracts,..
9/20/201911:41DJNForm 8.3 - [Allergan Plc]
9/19/201917:19EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/19/201910:57DJNForm 8.3 - Allergan Plc
9/18/201916:25EDGARStatement of Changes in Beneficial Ownership (4)
9/18/201910:35DJNForm 8.3 - Allergan Plc
9/17/201916:11EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
9/17/201910:48DJNForm 8.3 - Allergan Plc
9/16/201910:15DJNForm 8.3 - Allergan Plc
9/16/201907:57EDGARCurrent Report Filing (8-k)
9/16/201906:15EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
9/16/201906:09EDGARCurrent Report Filing (8-k)
9/16/201903:02DJNA Plan to Fight Hep C -- WSJ
9/13/201911:00DJNForm 8.3 - Allergan Plc
9/13/201910:20DJNLouisiana's Deal for Hepatitis C Drugs May Serve as Model --..
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.